Felix graduated with a first class MSci degree in Chemistry from Imperial College London in 2019. He has been accepted on the Technology Enhanced Chemical Synthesis (TECS) CDT programme at the University of Bristol. Felix is currently synthesizing a precursor to the antibiotic mupirocin to further elucidate its biosynthesis. He will soon start working on a project in collaboration with UCB Pharma on investigating the role of a-synuclein aggregates in the pathogenesis of Parkinson’s disease. Outside of the lab he can be found: drinking beers, exercising, or getting excited in the Wai Yee Hong Chinese supermarket.